According to IMARC Group latest published report, titled “Biopsy Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” that the global biopsy devices market size reached US$ 2.33 Billion in 2021. Looking forward, the market expected to reach a value of US$ 3.43 Billion by 2027, exhibiting a CAGR of 6.69% during 2022-2027.

Year Considered to Estimate the Market Size:

Base Year of the Analysis: 2021
Historical Period: 2016-2021
Forecast Period: 2022-2027

Biopsy devices assist surgeons, cardiologists and other medical practitioners in performing the surgical removal of tissues from any part of the body to examine the presence of a disease. They are also utilized for surgically removing a suspicious nodule or lump with the help of ultrasound, x-ray, computed tomography (CT), or magnetic resonance imaging (MRI). These imaging techniques determine precisely where the needle needs to be placed for performing the biopsy.

Competitive landscape

The competitive landscape of the market has been examined, with some of the key players being Argon Medical Devices, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Danaher Corporation, Hologic, Inc. and Medtronic PLC.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/biopsy-devices-market/requestsample

Global Biopsy Devices Market Trends:

According to the World Health Organization (WHO), cancer is one of the leading causes of death and resulted in around 9.6 million deaths across the globe in 2018. The increasing prevalence of the disease represents one of the significant factors strengthening the biopsy devices market growth. Apart from this, the increasing awareness among individuals about the availability of diagnostic and screening procedures for chronic diseases is positively influencing the demand for integrated technologies, such as stereotactic-guided biopsies.

Furthermore, the development of vacuum-assisted guns and smart biopsy systems are helping in distinguishing healthy cells from tumorous ones. Some of the other factors anticipated to bolster the market growth in the upcoming years are the growing geriatric population, rising healthcare expenditure, increasing initiatives undertaken by governing agencies of various countries and extensive research and development (R&D) activities.

The report cover the below key market segments:

Breakup by Procedure Type:

Surgical Biopsy
Needle Biopsy
Breakup by Product:

Biopsy Guidance Systems
Needle Based Biopsy Guns
Biopsy Needles
Biopsy Forceps
Others
Breakup by Application:

Breast Biopsy
Lung Biopsy
Colorectal Biopsy
Prostate Biopsy
Others
Breakup by Guidance Technique:

Ultrasound Guided Biopsy
Stereotactic Guided Biopsy
MRI Guided Biopsy
Others
Breakup by End-User:

Hospitals and Clinics
Academic and Research Institutes
Others
By Geography:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=1965&flag=C

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group
134 N 4th St.
Brooklyn, NY 11249 USA
Email: [email protected]
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800